e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Clinical issues in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience
L. Stehlík, M. Vašáková, J. Chlumský (Prague, Czech Republic)
Source:
Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Session:
Clinical issues in diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
843
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Stehlík, M. Vašáková, J. Chlumský (Prague, Czech Republic). Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience. Eur Respir J 2010; 36: Suppl. 54, 843
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Management of acute exacerbation of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=387
Year: 2006
Obstructive pulmonary disease with acute respiratory failure
Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=11
Year: 2001
Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Acute exacerbations of interstitial lung disease
Source: Eur Respir Monogr 2016; 74: 117-131
Year: 2016
Acute exacerbations of progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180071; 10.1183/16000617.0071-2018
Year: 2018
Predictors of failure of noninvasive ventilation (NIV) in acute respiratory failure due to chronic obstructive pulmonary disease
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013
Acute phase reactants as predictors for hospital mortality in acute respiratory failure due to COPD exacerbation
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients.
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Potential causes of acute deterioration in patients with interstitial lung disease
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Outcome predictors of noninvasive ventilation in patients with respiratory failure due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Diffuse parenchymal lung diseases presenting with acute hypoxemic failure
Source: International Congress 2017 – Pulmonary emergencies year in review
Year: 2017
Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Cardiovascular failure
versus
infectious disease as causes of exacerbation of COPD in a respiratory ICU
Source: Eur Respir J 2006; 28: Suppl. 50, 179s
Year: 2006
Incidence and outcome of lung cancer in patients with chronic respiratory failure
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Acute exacerbation admissions of fibrosing interstitial lung diseases – 3 years study
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Long-term effects of non-invasive ventilation in chronic respiratory failure due to chronic obstructive lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 280s
Year: 2002
The effect of early pulmonary rehabilitation on the treatment of ICU chronic obstructive pulmonary disease with severe respiratory failure
Source: International Congress 2018 – Muscles and diaphragm, and quality improvement
Year: 2018
Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure
Source: Annual Congress 2009 - Respiratory physiotherapy assessment
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept